arrow
BackJournal Details
Investigational New Drugs cover

Investigational New Drugs

IF2.7
Papers2999
Citations5614
Journal Papers 3032
Publication Date
Orelabrutinib combined with rituximab and high-dose methotrexate as induction therapy in newly diagnosed primary central nervous system lymphoma
delete2025-05-27
delete0
deleteOAAI
deleteXiao, Xi-Bin; Weng, Yi-Qin; Jiang, Hua-Wei; Li, Xian; Xie, Jing; Bao, Chang-Qian; Qian, Wen-Bin
deleteShare
deleteSave
Medulloblastoma associated with Lynch syndrome: a case report of germline MLH1 variant and tumor molecular characterization
delete2025-05-19
delete0
PREAI
deleteZheng, Han; Zhang, Gang; Jiang, Bin; Zhang, Luyi; Duan, Qianqian; Shi, Hangyu
deleteShare
deleteSave
TP53 and DNA-PK as potential biomarkers for enhanced efficacy of Olaparib in colorectal cancer
delete2025-05-16
delete0
PREAI
deleteKim, Do Yeon; Yun, Hyeseon; You, Ji-Eun; Park, Yoon Sun; Ryu, Yea Seong; Koh, Dong-In; Shin, Jae-Sik; Jin, Dong-Hoon
deleteShare
deleteSave
MicroRNA nanoformulation: a promising approach to anti-tumour activity
delete2025-05-14
delete0
PREAI
deleteBadal, Abhishesh Kumar; Nayek, Arnab; Dhar, Ruby; Karmakar, Subhradip
deleteShare
deleteSave
Evaluation of anti-leukemic activity and underlying mechanisms of the novel GSPT1 degrader AB138 in acute myeloid leukemia
delete2025-05-14
delete0
PREAI
deleteWang, Liqiang; Cai, Xin; Kong, Yang; Wu, Qingchun; Hu, Wei; Wang, Yongsheng
deleteShare
deleteSave
Unraveling BOLD-100 synergistic potential in pleural mesothelioma treatment: an in vitro study
delete2025-05-08
delete0
deleteOAAI
deleteBonsignore, Gregorio; Ranzato, Elia; Martinotti, Simona
deleteShare
deleteSave
Targeting Myc through BET-PROTAC elicits potent anti-lymphoma activity in diffuse large B cell lymphoma
delete2025-05-01
delete0
PREAI
deleteWang, Hui; Wu, Ximei; Chen, Suchang; Zhou, Zitao; Zhang, Luyong
deleteShare
deleteSave
Safety, tolerability, and preliminary efficacy of nadunolimab, an anti-IL-1 receptor accessory protein monoclonal antibody, in combination with pembrolizumab in patients with solid tumors
delete2025-05-01
delete0
deleteOAAI
deleteCohen, Roger B.; Jimeno, Antonio; Hreno, Jennifer; Sun, Lova; Wallen-Ohman, Marie; Millrud, Camilla Rydberg; Sanfridson, Annika; Garcia-Ribas, Ignacio
deleteShare
deleteSave
Novel GPC3 N-terminal bispecific antibody exhibits dual anti-tumor effect against tumor cells
delete2025-05-01
delete0
PREAI
deleteZhou, Xinsheng; Liu, Yixin; Liu, Xuan; Song, Xu; Li, Sijie; Chen, Peng; Jiang, Xiaotao; Li, Yongyin
deleteShare
deleteSave
An investigation of extended-interval dosing of atezolizumab in Japanese patients with advanced solid tumors: safety and pharmacokinetics of a dose of 1680 mg every 4 weeks
delete2025-05-01
delete0
deleteOAAI
deleteKondo, Shunsuke; Kitano, Shigehisa; Sato, Jun; Katsuya, Yuki; Kogawa, Takahiro; Mizugaki, Hidenori; Miyamoto, Ippei; Iwasawa, Shunichiro; Imaizumi, Tatsuki; Tomita, Hiroaki; Murakami, Chika; Miyake, Takeshi; Yamamoto, Noboru
deleteShare
deleteSave
Navigating antibody-drug conjugates (ADCs): from metastatic to early breast cancer treatment strategies
delete2025-04-30
delete0
deleteOAAI
deleteAwad, Lea; Chartouni, Antoine; Soueidy, Charbel; Kourie, Hampig
deleteShare
deleteSave
Discovery of potent CRBN-recruiting epidermal growth factor receptor (EGFR) degraders in vitro
delete2025-04-29
delete0
PREAI
deleteHu, Wenbo; He, Jinmei; Xie, Tianyu; Zhou, Mengjia; Liu, Mingxia; Wang, Xin
deleteShare
deleteSave
Phase 1 study of HP518, a PROTAC AR degrader in patients with mCRPC: results on safety, pharmacokinetics, and anti-tumor activity
delete2025-04-28
delete0
PREAI
deleteAzad, Arun A.; Gurney, Howard; Underhill, Craig; Horvath, Lisa; Voskoboynik, Mark; Li, Xinghai; King, Ivan; Shao, Lisa; Dai, Yiyun; Perabo, Frank
deleteShare
deleteSave
Glasdegib combined with chemotherapy in the treatment of patients with acute myeloid leukemia: a comprehensive meta-analysis
delete2025-04-26
delete0
PREAI
deleteShaban, Ahmed Yasser; Mohammed, Fatma; Marey, Mohamed Mahmoud; Aldemerdash, Mohamed A.; Abbas, Ahmed W.; Saeed, Omar; Saeed, Abdelrahman; Elhady, Mahmoud M.; Sharabati, Israa; Hamed, Mohamed; Abou-Shanab, Ahmed R. A.; Bahnasy, Ahmed; Abdelgawad, Hussien Ahmed H.
deleteShare
deleteSave
PANTAX: a phase Ib clinical trial of the efflux pump inhibitor SCO-101 in combination with gemcitabine and nab-paclitaxel in non-resectable or metastatic pancreatic cancer
delete2025-04-24
delete0
deleteOAAI
deleteShim, Susy; Reinacher-Schick, Anke; Kraeft, Anna-Lena; Tarpgaard, Line Schmidt; Ettrich, Thomas Jens; Kestler, Angelika; Christensen, Signe; Jandu, Haatisha; Nawabi, Mubeen; Roest, Nicklas Lindland; Damstrup, Lars; Vestlev, Peter Michael; Bruenner, Nils; Stenvang, Jan; Ladekarl, Morten
deleteShare
deleteSave
The up-regulated expression level of deubiquitinating enzyme USP46 induces the apoptosis of A549 cells by TRAF6
delete2025-04-23
delete0
PREAI
deleteZhao, Xuan; Li, Yanan; Gu, Dandan; Wang, Xiaoru; Han, Guangxin; Yao, Yasen; Ren, Limei; Yao, Qingguo; Li, Xiaobing; Qi, Yonghao
deleteShare
deleteSave